img 614-636-4850
  • Follow us:
Biosortia Pharmaceuticals is a biopharmaceutical company focused on the development of first-in-class small molecules as potential solutions to high priority unmet medical needs. With proprietary technologies and a team of accomplished scientists, Biosortia has opened the door to a new frontier of fascinating natural products and potential drug candidates that will positively impact human health.
"The microorganisms analyzed in the Biosortia biomass have shown more unique activity then I have seen in my 30 year career. This could materially change the landscape for natural products drug discovery research." Peter Moeller, PhD., NOAA’s Research Scientist
who leads the Toxins Natural Products Program